Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Vital Therapies, Inc.

TRADE

NASDAQ: VTLHealthcare / Biotechnology / USA
0.31-0.01-3.13%Vol 786 6061Y Perf -94.01%
Nov 14th, 2018 15:28
BID0.31 ASK0.31
Open0.31 Previous Close0.32
Pre-Market- After-Trading-
 - -%  - -%
Target Price
0.50 
Analyst Rating
Hold 3.00
Potencial %
56.25 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-38 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-54 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-96 
Income Ranking
 —    -
Market Cap (mil)13 
Earnings Rating
Price Range Ratio 52wk %
0.84 
Earnings Date

Today's Price Range

0.310.33

 

52wk Range

0.239.75

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-3.03%
3 Months
-96.38%
6 Months
-94.58%
1 Year
-94.01%
3 Years
-95.89%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
VTL0.31-0.0100-3.13
AAPL188.03-4.2000-2.18
GOOG1 051.2615.21001.47
MSFT106.09-0.8500-0.79
XOM77.71-0.2900-0.37
WFC52.39-0.3500-0.66
JNJ144.700.02000.01
FB145.052.89002.03
GE8.35-0.2600-3.02
JPM107.69-1.9000-1.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.70
Current Ratio 3.90
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.53
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.40
Cash Flow Per Share -1.06
Price to Tangible Book0.53
Book Value per Share0.62
Enterprise Value (in ths.)-17 181
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-112.14
ROE last 12 Months -108.51
Return on Assets (5Y Avg) -83.47
ROA last 12 Months -93.77
Return on Capital (5Y Avg) -105.38
ROC last 12 Months -109.94
Return on invested Capital Q -40.29
Return on invested Capital Y-97.20
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.28-
Q02 2018-0.33-0.309.09
Q01 2018-0.34-0.340.00
Q04 2017-0.30-0.35-16.67
Q03 2017-0.30-0.300.00
Q02 2017-0.30-0.293.33
Q01 2017-0.37-0.39-5.41
Q04 2016-0.33-0.37-12.12
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.2417.24Positive
12/2018 QR-0.2411.11Positive
12/2018 FY-1.11-344.00Negative
12/2019 FY-1.189.23Positive
Next Report Date7th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume786 606
Shares Outstanding (in ths.)42 370
Trades Count905
Dollar Volume239 982
Avg. Volume1 969 180
Avg. Weekly Volume1 926 444
Avg. Monthly Volume4 397 986
Avg. Quarterly Volume6 092 928

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

60%40%

Bearish Bullish

90%10%

Bearish Bullish

57%43%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (50.00 %)
Hold
1 (100.00 %)
2 (100.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Strong Buy
1.50

There are no comments yet.

News

x